Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Orthofix/Blackstone kickback case

This article was originally published in The Gray Sheet

Executive Summary

Arkansas surgeon Patrick Chan pleads guilty Jan. 3 to receiving illegal kickbacks from orthopedic device-makers Synthes and Blackstone Medical, which was acquired by Orthofix in 2006 (1"The Gray Sheet" Aug. 6, 2007, In Brief). Chan has also entered into a $1.5 million civil settlement with the U.S. government, the State of Arkansas and the "whistle-blower," an orthopedic device salesman who brought the case, in which Blackstone and Synthes are co-defendants, to the government's attention in 2006. Because Chan is expected to leave the country once sentenced, the prosecuting attorney filed a petition with the court Jan. 7 to first subpoena and depose him, since "Chan still has critical evidence on his remaining co-defendants' scheme to induce Chan and other surgeons to use the defendants' surgical products by paying them kickbacks under the guise of consulting agreements and similar arrangements.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel